China: In a promising development for pediatric care, a recent study has highlighted the efficacy of Ziresovir in treating ...

For infants and young children hospitalized with respiratory syncytial virus (RSV) infection, ziresovir reduces signs and ...

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio"), a clinical stage biopharmaceutical company focused on the development of ...

Current strategies to prevent severe RSV disease in infants include maternal vaccination with the RSV prefusion F vaccine ...

More than half of healthy term infants born in the United States are infected with respiratory syncytial virus (RSV) during ...

Lompoc Valley Medical Center has been presented with an Immunization-Friendly Birth Hospital award for its commitment to infant immunization. The award ...

A vaccine against RSV is available for the first time. Researchers in Scotland have been reviewing the evidence to find out how effective it is ...

A 32-year-old woman in the US had two litres of black and bloody liquid drained from her lungs due to severe damage from ...

MILLIONS of Brits have been urged to book a lifesaving new jab that offers 86 per cent protection against a killer lung ...

A proof-of-concept study promises the speedy diagnosis of lower respiratory tract infections through analysis of human breath.

Babies, young children, pregnant women and immunocompromised people are being urged to take up the COVID, flu and RSV vaccines this winter – here's why ...

A proof-of-concept study promises the speedy diagnosis of lower respiratory tract infections through analysis of human breath. The work is published in PNAS Nexus.